Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-21

Clinical Trial Update: Study of Naltrexone-Induced Blockade of Antidepressant Effects [Phase 4]

View source ↗

Summary

Phase 4 trial investigating naltrexone-induced blockade of antidepressant effects in major depressive disorder; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Marta Peciña, MD PhD | Conditions: Depression, Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-04-21